Dr Liz Mear, Chief Executive of the Innovation Agency, presented at NHS Confed 17 on Academic Health Science Networks (AHSNs) supporting strategic commissioning and bringing innovators, commissioners, clinicians and patients to together to develop closer collaboration and a demonstrably clearer understanding of NHS needs and opportunities.
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Academic Health Science Networks supporting strategic commissioning
1. Academic Health Science Networks
supporting strategic commissioning
Dr Liz Mear
Chair of the national AHSN Network, England
Chief Executive, Innovation Agency
@MearLiz
4. This goes from research to revenue:
from start-up to scale-up
UK Plc
Researchers /
Industry
CliniciansPatients
5. Key AHSN impacts since 2013
• 6.3M people have benefited from AHSN
activity
• 226 innovations have been adopted via
significant AHSN involvement
• Over £330M in innovation funding has
been leveraged by AHSNs
• AHSN-enabled innovations have been
implemented in over 11,400 sites
• Over 500 jobs have been created.
6. AHSN support
• Analytical capacity and skills to evaluate
complex data setsCapacity
• Support and links to innovative
technologies for the delivery of high
quality patient careIndustry links
• Engagement with academia; bridge
between researchers and
commissioners; signposting
Evidence/ research
into practice
7. AHSN support
• Sharing best practice across systems
and across AHSNs
System/England
wide
collaboration
• Promotion and support of economic
growth and engagement with non-
NHS organisations and across wider
systems
Economic and
social wellbeing
8. Interoperability and learning from data for
future commissioning – one example
Quality Improvement
Academic rigour Specialist expertise
Infrastructure
9. 9
The Innovation PathwayThe Innovation Pathway
AHSNs help
companies &
innovators navigate
a fragmented
landscape
10. Relative
reduction in
hip fracture
incidence
following
four years
bone sparing
therapy
based on
1500 patients
(Cochrane
2008)
59
Hip
Fractures
avoided
£960,000
Direct
savings in
acute hip
fractures
Pilot with Amgen –
system to optimise
medicines for
osteoporosis patients
Potential for reducing hip fractures:
11. 7,870 identified as benefitting
from intervention to optimise
medicines use
39,350 patients
in audit
Study highlighted opportunities to improve treatment of osteoporosis and
reduce the risk of fractures
Study showed potential to improve treatment
and avoid fractures
12. A unique opportunity to enhance evidence based approaches to
commissioning that supports a culture of innovation,
improvement and transformation.
Clinical Commissioning Evidence Champions
13. Clinical Commissioning Evidence Champions
Who
• Clinical Commissioners and GPs (11 in total)
• From CCGs and local authorities
What
• PG Cert Professional Practice (Evidence Based Commissioning)
through Lancaster University
How
• Students reported improved confidence in using evidence
• Work based project – practical application and reflection of
how to put evidence into practice
14. Right evidence, better decisions
Our aim is to put good research
evidence at the heart of
decision making in the NHS,
public health and social care.
Dedicated NIHR Dissemination
Centre
http://www.dc.nihr.ac.uk/emai
l-sign-up
16. Events to support collaboration across systems
Ecosystem Series
supporting mobile health and
electronic health, connecting
businesses, academia, NHS and
local authorities
Hackathons
Connecting businesses with health
professionals and patients to ‘hack’
solutions
17. Presentation 1
17 Innovation Fellows:
innovative health technologies and services into action
Francis White spreading
the use of Kardia from
AliveCor, the UK’s first
mobile heart monitor
Dr Lloyd Humphries
Patient Knows Best
Dr Penny Newman
Health Coaching
National Innovation Accelerator
18. Presentation 1
• 469 additional NHS providers and commissioners using NIA
innovations
• £28.6m+ raised in funding for life science businesses
• 14 awards won, 10 selling internationally
• Impacts around earlier intervention,
• reduced emergency admissions,
• reductions in complications, cost
• savings
AliveCor, the UK’s first mobile
heart monitor
National Innovation Accelerator
20. Listening and involving the public – PIES and PIGs
• AHSNs engage patients and the
public
• Consultation and feedback on
innovations; part of projects such as
preventing AF-related strokes; and
testing self-care tech
• National forum of AHSN Patient and
Public Involvement Leads share
learning and solve problems
together
“The Citizens Senate…
ensures that patients can play
a greater role in the design
and delivery of improvement.”
Trevor Fernandes
Co-chair East of England
Citizens’ Senate
“I am impressed with the
work of the AHSNs’
pioneering new approaches
to self-management with
the voluntary sector and
directly with patients.”
Hilary Newiss
Chair, Patient Voices
21. AHSNs’ future role
• Aligned with national innovation and
improvement aims
• With local direction from transformation
partnerships and our regional stakeholders
22. Our shared objectives
• Innovators, commissioners, clinicians and patients develop
closer collaboration and a demonstrably clearer
understanding of NHS needs and opportunities
• Patients, residents and the NHS have demonstrably faster
access to cost effective innovations and improvements
• Patients are demonstrably safer and systems are
demonstrably more focused on continual leaning and
improvement of patient care
23. Dr Liz Mear
Chief Executive
E: Liz.Mear@innovationagencynwc.nhs.uk
T: (0044) 1772 520260
Email us: info@ahsnnetwork.com
Visit us: www.ahsnnetwork.com
For more information…
Editor's Notes
15 Academic Health Science Networks (AHSNs) across England
Uniquely connect NHS, academic organisations, LA’s, 3rd sector & industry
We do this by
Bringing people, resources & organisations together quickly, delivering benefits that couldn’t be achieved alone
Support the development of healthcare innovations & technologies by SME’s
Drive commercial return for SME’s through supporting adoption, procurement & supply into to the NHS market
National annual call: supporting proven innovation to be adopted faster for patient benefit at reduced cost
The aim of the NIA is to deliver on the commitment detailed within the Five Year Forward View – creating the conditions and cultural change necessary for proven innovations to be adopted faster and more systematically through the NHS, and to deliver examples into practice for demonstrable patient and population benefit. After a successful first year, the NIA 2016 opens for applications from healthcare innovators on Friday 17 June.
This round of applications will focus on three challenges based on population health needs:
Prevention
Early intervention
Long term condition management
National annual call: supporting proven innovation to be adopted faster for patient benefit at reduced cost
The aim of the NIA is to deliver on the commitment detailed within the Five Year Forward View – creating the conditions and cultural change necessary for proven innovations to be adopted faster and more systematically through the NHS, and to deliver examples into practice for demonstrable patient and population benefit. After a successful first year, the NIA 2016 opens for applications from healthcare innovators on Friday 17 June.
This round of applications will focus on three challenges based on population health needs:
Prevention
Early intervention
Long term condition management
· This was an industry collaboration with Amgen, testing a new osteoporosis audit tool
· The tool interrogated practice clinical systems to identify:
o Patients at risk of osteoporosis requiring assessment
o Patients known to have osteoporosis but not on optimal treatment
o Patients known to have osteoporosis who may benefit from a change in treatment
· The funding paid for a clinical pharmacist to visit practices and run the tool then feedback to GPs
· Practices volunteered to participate
· We ran the tool initially in CCGs with the highest rate of hip fractures
The audit identified nearly 8,000 opportunities, across the test site, to optimise osteoporosis patient care and improve local performance against national indicators and targets.
The audit results showed that there are manageable groups of patients already with or at risk of osteoporosis that may
benefit from having their medication optimised to reduce their fracture risk.
The project found that by splitting the patients into subgroups based on their medication and clinical history, practices should be better placed to prioritise patients for review either proactively or at next contact.
Hackathon July 2016 – Collaborate to Improve Care, in partnership with Chief Scientific Officer Sue Hill. Focus on improving care in care homes. Winner was a project to produce a mobile phone based system to test the hearing of care home residents, improving the quality of care
We support the National Innovation Accelerator along with UCLPartners. 17 Fellows with innovative technologies or practices.
In its first year, the 17 fellows who joined the programme received support to take their high impact innovations to more than 345 NHS providers and commissioners, raised over £17m in funding and won 12 awards.
We support 3 Fellows – Francis White, Penny Newman and Lloyd Humphries.
Each year, the NIA looks for the best national and international evidence-based healthcare innovators. Another 8 Fellows are currently being recruited – the results of the applications will be announced in November 2016.
As our therapeutic area are unplanned care in COPD and alcohol misuse it has been difficult to recruit patients in some areas. Patient advocates who work regularly with patients dependent on alcohol are members of the Senate including one representing the Whitechapel Centre in Liverpool who support those with alcohol dependency and also those who are homeless. Focus groups have been held with those recovering from alcohol dependency at Genie in the Gutter.
Innovation Lead for Patient and Public Involvement, Debbie Parkinson, has formed a patient group at The Royal Liverpool Hospital after liaising with Senior Nurse Specialists and the Hospital Board to gain permission to sit in clinics and interview patients on their views of sharing their healthcare data. Patients attending Liverpool and Aintree Hospitals will be identified by clinicians to work with CHC and with their consent be tracked on their care pathway and feedback gained throughout their journey.
The Innovation Agency ensure patient voice is incorporated in our work and Senate members are involved in Patient Safety steering group, Innovation Exchange selection panel, Interviews for Innovation staff and one has recently acted as judge for the BMJ shortlisting for the awards with Dr Liz Mear.
Patient Involvement and Engagement Senate; Patient Involvement Groups
AHSNs are very strong on public engagement - engaging diverse communities, supporting genuine co-production of health and care services, and enabling self-management so patients have more control of their care.
In the North of England, patient and public representatives are central to our work on the £20m Connected Health Cities programme, which is using shared data to improve clinical pathways and for research.